<DOC>
	<DOCNO>NCT02678793</DOCNO>
	<brief_summary>Subjects complete study 4975-MN-202 eligible receive open-label treatment CNTX-4975 200 Âµg study 4975-MN-203 meet inclusion/exclusion criterion .</brief_summary>
	<brief_title>An Study Evaluate Safety Efficacy CNTX-4975 Subjects With Painful Intermetatarsal Neuroma ( Morton 's Neuroma )</brief_title>
	<detailed_description />
	<mesh_term>Neuroma</mesh_term>
	<criteria>1 . Male female age &gt; 18 year time Screening Visit . 2 . Completion study 4975MN202 . 3 . Female childbearing potential , defined postmenopausal least 1 year , surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) , practice one follow medically acceptable method birth control throughout study period : 1 . Hormonal method oral , implantable , injectable , transdermal contraceptive minimum 1 full cycle ( base subject 's usual menstrual cycle period ) investigational product ( IP ) administration . 2 . Total abstinence sexual intercourse since last menses IP administration . 3 . Intrauterine device . 4 . Double barrier method ( condom , sponge , diaphragm , spermicidal jelly cream ) . 4 . Willing able understand study requirement , abide study restriction , complete study procedure , pain scale , weekly IWRS/IVRS entry , communicate meaningfully study personnel . 5 . Signed Informed Consent Form approve Institutional Review Board . 6 . Subject agrees take rescue medication neuroma foot pain time screen study completion , agree discontinue topical medication neuroma pain Screening . 1 . Other chronic pain anywhere body severe intensity would interfere subject 's ability evaluate foot pain intermetatarsal neuroma . 2 . Signs arterial insufficiency foot , include clinically meaningful edema . 3 . Raynaud 's disease phenomenon , previous frostbite , cause vascular instability foot result application cold foot . 4 . Daily use opioids condition . 5 . Corticosteroid injection affect foot within 30 day Screening . 6 . Presence medical condition ( take medication ) unstable health status , judgment investigator , might adversely impact conduct study result data , include chronic condition likely alter rate heal likely result safety complication unrelated study medication , uncontrolled diabetes mellitus vascular disease . 7 . Clinically significant abnormal laboratory result Screening Visit ( opinion investigator ) . 8 . Has positive pregnancy test Screening Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>